Last Updated: November 13, 2026

Sagent Company Profile

« Back to Dashboard

What is the competitive landscape for SAGENT

SAGENT has ninety-two approved drugs.

There is one tentative approval on SAGENT drugs.

Summary for Sagent

US Patents:	0
Tradenames:	72
Ingredients:	69
NDAs:	92
Patent Litigation for Sagent:	See patent lawsuits for Sagent

Drugs and US Patents for Sagent

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sagent Pharms Inc	FLUOROURACIL	fluorouracil	INJECTABLE;INJECTION	203609-001	Feb 17, 2016	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms	HEPARIN SODIUM PRESERVATIVE FREE	heparin sodium	INJECTABLE;INJECTION	090810-001	Jun 30, 2010	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	DESMOPRESSIN ACETATE	desmopressin acetate	INJECTABLE;INJECTION	204695-001	Aug 22, 2017	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
Sagent Pharms Inc	PIPERACILLIN AND TAZOBACTAM	piperacillin sodium; tazobactam sodium	INJECTABLE;INJECTION	208674-001	Feb 16, 2021	AP	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.